Group 6 Copy 51
-2
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Does hearing gum chewing increase stress in students?

    This study can help to uncover smaller stress factors that affect teens. Studying the effect of hearing gum...

    What risks do ticks confer to the humans and animals of Guam?

    There is an abundant population of ticks on Guam, which can cause devastating illness in animals. Many animals...

    Backer Badge Funded

    A biology project funded by 47 people